Your global research partner in accelerating insights into complex genetic diseases
Expert in simultaneous genome sequencing and clinical data analysis to identify disease causing genetic mutations | 1800 103 3691


Irreversible Electroporation Combined with Checkpoint Blockade and TLR7 >>
Journal of Cancer Immunology Research,
7(10): 1714-1726, October 2019
Irreversible electroporation (IRE) is a nonthermal ablation technique that is used clinically in selected patients with locally advanced pancreatic cancer, but most patients develop recurrent distant metastatic disease.
Jayanth S. Shankara Narayanan, Partha Ray, Tomoko Hayashi, Thomas C. Whisenant, Diego Vicente, Dennis A. Carson, Aaron M. Miller, Stephen P. Schoenberger and Rebekah R. White
Unmasking tumor heterogeneity and clonal evolution by single-cell analysis >>
Journal of Cancer Metastasis and Treatment,
4:47, 31 August 2018
The intratumoral heterogeneity orchestrated by the tumor intrinsic and extrinsic mechanisms enable cancers to persist and spread notwithstanding the use of aggressive interventional therapies.
Xiaoshan Shi, Papia Chakraborty, Amitabha Chaudhuri
The GenomeAsia 100K Project enables genetic discoveries across Asia >>
Nature volume 576, pages106–111(2019)
The underrepresentation of non-Europeans in human genetic studies so far has limited the diversity of individuals in genomic datasets and led to reduced medical relevance for a large proportion of the world’s population.
GenomeAsia100K Consortium


07th - 10th December, 2019
Meet us at Booth No. 2417 at ASH Annual Meeting & Exposition 2019
Orlando, FL, USA
22nd - 25th November, 2019
48th Annual Meeting of the Autumn Immunology Conference
Chicago, Illinois, USA
20th - 22nd November, 2019
NeoAg Summit 2019
Boston, MA
2019 Ⓒ Medgenome. All Rights Reserved